The Zhitong Finance App learned that on Friday, Bright Minds Biosciences (DRUG.US) opened sharply, surging 52 times in 5 trading days, to a record high. As of press time, it had risen more than 165 percent to $57.72. According to the news, the company announced today that it will conduct private equity financing for non-brokered common shares at a price of $21.70 per share (“share issuance”). In addition to shares issued under a stock offering, the company reserves the right to issue each PFW (“PFW offering”) at $21.699 per PFW (“PFW offering”) for each pre-funded corporate warrant (PFWs), together with the share offering. The total gross proceeds from the stock issuance and the PFW offering amounted to $35 million. The company may decide for itself how many PFWs to issue under PFW issuance and how many shares to be issued based on stock issuance.

Zhitongcaijing · 10/18 14:57
The Zhitong Finance App learned that on Friday, Bright Minds Biosciences (DRUG.US) opened sharply, surging 52 times in 5 trading days, to a record high. As of press time, it had risen more than 165 percent to $57.72. According to the news, the company announced today that it will conduct private equity financing for non-brokered common shares at a price of $21.70 per share (“share issuance”). In addition to shares issued under a stock offering, the company reserves the right to issue each PFW (“PFW offering”) at $21.699 per PFW (“PFW offering”) for each pre-funded corporate warrant (PFWs), together with the share offering. The total gross proceeds from the stock issuance and the PFW offering amounted to $35 million. The company may decide for itself how many PFWs to issue under PFW issuance and how many shares to be issued based on stock issuance.